These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17086007)

  • 1. Medical devices and pharmaceuticals: differences in public acceptance.
    Holmes DR; Wood DL
    Am Heart Hosp J; 2006; 4(4):269-72. PubMed ID: 17086007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety.
    Janetos TM; Ghobadi CW; Xu S; Walter JR
    Am J Obstet Gynecol; 2017 Jul; 217(1):42-46.e1. PubMed ID: 28500861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental Cost-Effectiveness Ratio and Net Monetary Benefit: Promoting the Application of Value-Based Pricing to Medical Devices-A European Perspective.
    Messori A; Trippoli S
    Ther Innov Regul Sci; 2018 Nov; 52(6):755-756. PubMed ID: 29714590
    [No Abstract]   [Full Text] [Related]  

  • 4. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators.
    Maisel WH; Sweeney MO; Stevenson WG; Ellison KE; Epstein LM
    JAMA; 2001 Aug; 286(7):793-9. PubMed ID: 11497532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sanctions on procurement of medicine and medical devices in Iran; a technical response.
    Hosseini SA
    Arch Iran Med; 2013 Dec; 16(12):736-8. PubMed ID: 24329148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations.
    Shiroiwa T; Fukuda T; Ikeda S; Takura T
    Health Policy; 2017 Aug; 121(8):836-841. PubMed ID: 28687183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-printing and the effect on medical costs: a new era?
    Choonara YE; du Toit LC; Kumar P; Kondiah PP; Pillay V
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):23-32. PubMed ID: 26817398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the ventricular assist device programme in the UK.
    Sharples L; Buxton M; Caine N; Cafferty F; Demiris N; Dyer M; Freeman C
    Health Technol Assess; 2006 Nov; 10(48):1-119, iii-iv. PubMed ID: 17134596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistics in the world of medical devices: the contrast with pharmaceuticals.
    Campbell G
    J Biopharm Stat; 2008; 18(1):4-19. PubMed ID: 18161538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories.
    Maisel WH; Stevenson WG; Epstein LM
    Pacing Clin Electrophysiol; 2002 Dec; 25(12):1670-8. PubMed ID: 12520666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A primer on the assessment of medical technologies.
    Matuszewski KA
    Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study.
    Hwang TJ; Sokolov E; Franklin JM; Kesselheim AS
    BMJ; 2016 Jun; 353():i3323. PubMed ID: 27352914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Medical Devices Yield Savings throughout Healthcare, Says Boisier.
    Boisier P
    Biomed Instrum Technol; 2016; 50(1):63-7. PubMed ID: 26829143
    [No Abstract]   [Full Text] [Related]  

  • 15. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy?
    Amin MS; Ellenbogen KA
    Curr Opin Cardiol; 2010 Jan; 25(1):23-8. PubMed ID: 19907318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.